The New York Times published an article suggesting that Psymposia, a nonprofit advocating for psychedelic therapy, undermined FDA approval for MDMA-assisted therapy by making baseless accusations. The discourse has been fueled by a narrative from groups like Heroic Hearts Project and retweeted by Robert F. Kennedy Jr. As an observer of the psychedelic movement, the journalist found the Times article misleading, noting it lacked a comprehensive account of the factors behind the failure of Lykos Therapeutics' application, while fostering a damaging narrative against Psymposia and its supporters.
On Feb. 4-the same day that Robert F. Kennedy Jr.'s nomination for secretary of Health and Human Services advanced out of the Senate finance committee-the New York Times published a story with the headline "How a Leftist Activist Group Helped Torpedo a Psychedelic Therapy." The story claims that Psymposia, a psychedelic-science and harm-reduction nonprofit consisting of five unpaid volunteers, used baseless and misleading accusations to thwart Food and Drug Administration approval of MDMA-assisted therapy, or MDMA-AT.
The core argument about Psymposia outlined in the New York Times article-that individuals from the organization deliberately raised baseless, inflammatory allegations in a vendetta against Lykos and veterans-isn't new. It's an allegation initially posited by the Heroic Hearts Project, an organization that advocates for veterans' access to psychedelic therapy.
Collection
[
|
...
]